â€˜¿ wash-out' period before being admitted to one of the trials.
Duringthe trialstheyreceivedno other medication,apart from a patient who was already on lithium carbonate (see below). All were rated on the Beckand Hamilton scales initially and on the fourteenth day.
Twenty-sevencoursesof SAMweregivento 25 patients (11 bipolarand 14unipolar),and placebo was given to four patients (all umpolar). Twenty patients received SAM intravenously, and seven orally. Two patients were
given SAM both intravenously and orally. The character istics of all these patients are described in Table! . The mean age of the whole group was 51 years (range 20â€"82).
Five degreesof response were recognisedas follows:
(1) depression no better, slightly better or worse (14 patients)
(2) improved: Hamilton score reduced by 50'lo or more (6 patients) (3) elevatedmoodasreportedbythepatientandconfirmed by medical and nursing staff, accompanied by in creased production of speech and motor activity (2 patients; in both, this diagnosis was confirmed by video recordings seen and agreed by all the in vestigators) travelledto Brighton and was returned to the psychiatric unit after being involved in a fight at Brighton station with police, who had been attracted by his bizarre behaviour.
Considerationof previousreports indicatedthat the last three degrees of mood elevation should constitute switching.
Results
Sixteen patients made a good initial improvement: one of these (a neurotic depressive)relapsed within the first 14 days;for the restthe improvement wasenduring.Themean
Hamilton score of the responders fell from 23.3 to 4.8, while
that of the non-responders remained virtually unchanged (24,8 and 22 .0 respectively).
Switches
Nine(3lt@1o) of the 29patientsprogressedto elevatedmood change (Table II) . Nine of the 11 bipolars switched, but nounipolar switched (P<0.00l; Fisher's Exact Probability Test). The two bipolar patients who receivedtwo courses of SAMat differenttimes,switchedon eachoccasion.Nine of the 11switchesfolloweda briefeuthymicintervalranging from a few hours to six days (mean 3.2 days), the tenth switch immediately followed SAM, and the eleventh did not occur until the 42nd day of oral SAM. All the â€˜¿ switchers' were endogenous bipolar patients. No unipolar patient switched, and no non-endogenous patient switched or improved for more than 14 days.
The bipolars who switched differed from the non switching bipolars and the umpolars (Table I) in being the youngest and having the highest mean Newcastlescore.
Non-switching bipolars, on the other hand, had had most previous episodes of affective illness and scored most highly on the Hamilton and Beck scales. However, the numbers in these subcategories are small. The probability(Poisson)of theseswitchesoccurringby chance within six days of starting SAM is remote (P<0.OOl), given a switch rate of 10-14Â°!. over a six-month period (Bunney, 1978; Lewis & Winokur, 1982) . Theymay, therefore,havebeenprovokedby SAM.Certainlynonewas seen among the placebo patients, though their numbers were very small.
Among the unipolar patients (Table II) The â€˜¿ switchers' (Table III) showed an increase in HVA (43Â°!, in the first patient and 13Â°!. in the second). Among the remaining six patients -of whom three improved and three did not respond -HVA also tended to increase. All these patients except one received SAM treatmenL The patientwho receivedplacebo injectionswas also on lithium carbonate therapy and had high levels of 5HIAA and HVA before and after treatment.
Discussion
This report is about the phenomenon of switching rather thana controlled trial of SAM. The most remarkable finding was the close association of switching with elated mood and bipolar affective illness. Sporadic cases of switching into elated mood have previously been linked with SAM (Lipinski eta!, 1984) and folate (Reynolds, 1981) . One problem is that ofdefinition. Ifwe defmeswitching aschanging from depressed mood into elated mood, then 82Â°!.
of our bipolar patients switched. If, on theother hand, we define switching as showing remission of depressive symptoms (i.e. moving out of depression), then68% ofthedepressed bipolars andendogenous umpolar patients switched or improved. We chose thefirst definition. Allthese patients received oral or intravenous SAM, no placebo-treated patient switching or showing sustained improvement. Oral andintravenous SAM areequally efficacious inthis respect (Carney, 1987) .
What are the possible explanations of this high rateof switching (regardless of definition)? The spontaneous switch rate in untreated unipolar and bipolar depression has been reported to be 10â€"14% overa six-month period (Bunney, 1978; Lewis& Winokur, 1982) . Angst (1987) thought that in one third of all episodes there was a switch to an opposite mood state. He reported that mild and severe episodes seemed to have the same switch rate. Among bipolar females, generally, more depressive episodes occurred and,inaddition, manicepisodes showed a higher switch rate (40Â°!.) than depressive episodes (26Â°lo). Angst did not believe that the introduction of neuroleptic drugs in the 1950s changed theswitch rate. He thought that theswitch rate in bipolar disorders from depression to mania had remained stable over the decades of this century at 29%. Unipolar depression had shown a non gignicant increase from 2. 7% (1920â€"1957) to 4.6% (1958â€"1981) . He could not exclude as a cause the introduction of tricycic antidepressants, or possibly a higher incidence of latent bipolars.
We found that the switch occurred soon after the patient started taking SAM. Thisisincontrast with Angst's (1987) fmding that it did not occur, on average, until 50 days after admission to hospital. However, like us, Angstthought that theswitch into hypomania only occurred in actual or potential bipolar patients. Switches into elated mood have also been linked with stress of various kinds, life events, environ mentalfactors and ECT. Allthepresent patients wereinhospital overtherelevant period and thus were screened from many environmental influences, andnonereceived ECF. Itseems unlikely, therefore, that our observed switches were secondary to these factors. Neither was there evidence of the recent involvement of therapeutic drugs(apart from the patient on lithium) or illicit drugs like amphetamines.
On theother hand,all ourpatients wereon SAM atoraroundthetimeofimprovement orswitching, so there is a strong suggestion of a causal link. This is reinforced by the occurrence of changes inCSF 5HIAA and HVA inSAM-treated butnot in placebo-treated patients in a double-blind SAM is the principal methyl donor in brain !nd derives its methylgroupsforthese reactions from methylfolate through thesynthesis ofmethionine, the precursor of SAM, as a result of the activity of methionine adenosyl transferase. Methy lation processes (and folic acid and SAM meta bolism) may therefore be construed as essential for the maintenance of the monoamine basis of normal mood (Reynolds et a!, 1984 Finalconfirmation of the roleof SAM in promoting switches out of depression or into elated mood awaits definitive controlled trials of methyl folate and SAM. suggest an effect on dopamine metabolism.
